Resistance of Uropathogenic Staphylococci to Commonly Used Antimicrobials for Treatment of Urinary Tract Infections

This study addresses the pressing issue antibiotic resistance in uropathogenic staphylococci secludedfrom female patients with acute urinary tract infection (UTIs) in Iraq. Antibiotic resistance, driven by the overuse andmisuse of antimicrobials, presents a major public health challenge worldwide. The research focuses on determiningthe resistance patterns of these bacteria to routinely used antibiotics and developing viable therapy choices.Samples were taken from patients aged 18 to 40 years at Al-Hajj Jalal Hospital in Wasit Province, Iraq, over a six-month period. Urinalysis, bacterial culturing, biochemical, and molecular identification methods, including 16S rRNAgene amplification, confirmed the presence of Staphylococcus spp. Antimicrobial susceptibility tests were performedusing Kirby-Bauer's disc diffusion method with various antibiotics.Results revealed a high prevalence of Gram-positive cocci (81.0%), predominantly Staphylococcus species, amongUTI isolates. Alarmingly, staphylococcal isolates exhibited significant resistance to β-lactam antibiotics such aspenicillin (84.4%) and cefoxitin (61.4%). Resistance to other antibiotics, namely gentamicin, norfloxacin, andtrimethoprim were 37.6%, 27.5% and 34.8%, respectively. However, lower resistance rates were observed fornitrofurantoin (7.3%) and ciprofloxacin (20.1%), supporting their use as first-line therapies.The study emphasizes the critical need for antimicrobial stewardship, localized resistance monitoring, and routinesusceptibility testing to optimize UTI treatment strategies. Additionally, it advocates for further research to understandthe genetic mechanisms of resistance and explore alternative therapeutic options. These findings underscore the globalurgency of addressing antibiotic resistance to improve patient outcomes in managing UTIs.